Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr)-Reference-Cited by-同舟云学术

Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr)

Published:2022-04-10 Issue:3 Volume:24 Page:281-292
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatr Drugs

Author:

Zitouni Jinane,Beauchet Alain,Curmin Raphaëlle,Di Lernia Vito^ORCID,Bursztejn Anne-Claire^ORCID,Mazereeuw-Hautier Juliette^ORCID,Gottlieb Jérémy,Lasek Audrey,Aubert Hélène,Droitcourt Catherine,Bulai-Livideanu Cristina^ORCID,Fortina Anna Belloni^ORCID,Caroppo Francesca,Quiles-Tsimaratos Nathalie,Mallet Stéphanie,Barthélémy Hugues,Puzenat Eve,Bouilly-Auvray Danielle,Neri Iria,Phan Céline,Mahé Emmanuel^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s40272-022-00501-6.pdf

Reference33 articles.

1. Nast A, Gisondi P, Ormerod AD, et al. European S3—guidelines on the systemic treatment of psoriasis vulgaris—update 2015–Short version—EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29:2277–94.

2. Mahé E, Amy-De La-Bretêque M, Phan C. Perspectives on the pharmacological management of psoriasis in pediatric and adolescent patients. Expert Rev Clin Pharmacol. 2021;14:807–19.

3. Menter A, Cordoro KM, Davis DMR, et al. Joint American academy of dermatology-national psoriasis foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82:161–201.

4. Eisert L, Augustin M, Bach S, et al. S2k guidelines for the treatment of psoriasis in children and adolescents—short version part 2. J Dtsch Dermatol Ges. 2019;17:959–73.

5. Fortina AB, Bardazzi F, Berti S, et al. Treatment of severe psoriasis in children: recommendations of an Italian expert group. Eur J Pediatr. 2017;176:1339–54.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological therapies for the treatment of psoriasis in pediatrics;Expert Opinion on Biological Therapy;2023-11-10

2. Effectiveness of biologic therapies in children with palmoplantar plaque psoriasis: An analysis of real‐life data from the BiPe cohorts;Pediatric Dermatology;2023-07-13

3. Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials;American Journal of Clinical Dermatology;2023-06-21

4. Quoi de neuf en dermatologie pédiatrique en 2022 ?;Annales de Dermatologie et de Vénéréologie - FMC;2022-12

5. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real‐life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists;Dermatologic Therapy;2022-09-22